Reporte zur Charge FN6197

Symptomtext

Pain level 9 in right shoulder; radiating to the neck; This is a spontaneous report from a contactable consumer, the patient. A 67-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FN6197) via an unspecified route of administration in the left arm on 12Mar2021 at 09:30 (at the age of 67-year-old) as a single dose for COVID-19 immunisation. Medical history included stomach cancer and bladder cancer. The patient had no allergies to medications, food, or other products. Concomitant medications included imatinib mesilate (GLEEVEC) for cancer treatment from an unknown date. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EM9809) via an unspecified route of administration in the arm left on 19Feb2021 at 13:15 (at the age of 67-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021, the patient experienced pain level 9 in the right shoulder and was radiating to the neck. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event pain level 9 in the right shoulder and radiating to the neck was not recovered at the time of the report. No follow-up attempts are needed. No further information is expected.